Antimicrobial Drugs and Community–acquired Clostridium difficile–associated Disease, UK

Antimicrobial Drugs and Community–acquired Clostridium difficile–associated Disease, UK

In a population-based case-control study of community-acquired Clostridium difficile–associated disease (CDAD), we matched 1,233 cases to 12,330 controls. CDAD risk increased 3-fold with use of any antimicrobial agent and 6-fold with use of fluoroquinolones. Prior use of antimicrobial agent did not...

Full description

Bibliographic Details
Main Authors: J. A. Chris Delaney, Sandra Dial, Alan Barkun, Samy Suissa
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2007-05-01
Series:Emerging Infectious Diseases
Subjects:
Clostridium difficile–associated disease
antimicrobial agents
fluoroquinolones
risk factors
epidemiology
dispatch
Online Access:https://wwwnc.cdc.gov/eid/article/13/5/06-1124_article

Internet

https://wwwnc.cdc.gov/eid/article/13/5/06-1124_article

Similar Items